You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-05-08
Court	District Court, D. Delaware	Date Terminated	2020-09-11
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	6,841,716; 8,231,906; 9,724,310; 9,730,900; 9,833,419
Link to Docket	External link to docket

Small Molecule Drugs cited in Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Noven Pharmaceuticals, Inc. v. Amneal Pharmaceuticals LLC (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-03-08	112	Opinion - Memorandum Opinion	infringement of U.S. Patent Nos. 9,730,900 (the "' 900 Patent"), 9,724,310 (the '"…quot; 310 Patent"), and 9,833 ,419 (the '" 419 Patent") (collectively, "patents-in-suit…-suit" or "asserted patents"). (D.I. 83 at 3) The patents-in-suit relate "to transdermal…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification	External link to document
2018-06-01	13	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,841,716 . (Wilson, Samantha… 11 September 2020 1:18-cv-00699 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2021-09-03	249	Order - -Memorandum and Order	of U.S. Patent Nos. 9,833,419 (the “419 patent”), 9,730,900 (the “’900 patent”), and 9,724,310 (the “°… infringes the °419 patent; (2) Amneal’s product does not infringe the °900 patent under the doctrine … does not infringe the ’310 patent under the DOE; (4) the asserted patents are invalid for lack of enablement…the asserted patents claimed transmucosal patches; (2) the specification of the patents contained no …notified Innovation that the ’140 patent was legally insufficient either as patent ineligible subject matter	External link to document
2018-07-05	25	Consent Judgment - Proposed	PROPOSED CONSENT JUDGMENT with respect to U.S. Patent No. 6,841,716, by Hisamitsu Pharmaceutical Co. Inc.. (… 11 September 2020 1:18-cv-00699 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.